NCT00003441 2018-10-25
Irofulven in Treating Patients With Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
6 trialsNCT00003666 2016-07-20
Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00003786 2014-03-07
Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer
University of Chicago
Phase 2 Withdrawn
NCT00005070 2013-06-19
Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00005968 2013-05-30
Irofulven in Treating Patients With Stage IV Melanoma
University of Colorado, Denver
Phase 2 Completed
NCT00003760 2012-08-09
Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
The University of Texas Health Science Center at San Antonio
Phase 2 Completed